Sort
172,184 grants matching “inflammation”
Husbandry and Management Core
$831,363Jeffrey A Roberts · University Of California At Davis · U42 · FY2020 · OD
Role of Placenta Growth factor in Sickle ACS
$831,359Malik Punam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2008 · HL
The Physiology of Store-Operated Channels in the Nervous System
$831,293Murali Prakriya · Northwestern University At Chicago · R35 · FY2023 · NS
Inhibition Of Renal Injury
$831,292Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Biomechanics and Inflammation in Osteoarthritis
$831,252Farshid Guilak · Duke University · P01 · FY2011 · AR
Proteomic signatures to identifypathways underlying the progression toheart failure
$831,215Amil M Shah · Brigham And Women'S Hospital · R01 · FY2022 · HL
The Integrated Stress Response in Human Islets During Early T1D
$831,197Raghavendra G Mirmira · University Of Chicago · U01 · FY2020 · DK
Vascular smooth muscle cell heterogeneity and disease
$831,140Michael Simons · Yale University · R01 · FY2023 · HL
Substance Use and Immunity in HIV+ Adolescents by Systems Biology
$830,938Maureen M Goodenow · University Of Florida · R01 · FY2013 · DA
A Randomized Controlled Trial of Home Air Purification for Eosinophilic COPD
$830,873Mary B Rice · Beth Israel Deaconess Medical Center · R01 · FY2020 · ES
The functional role of the cPLA2alpha/C1P interaction in sepsis resolution
$830,847Charles E Chalfant · Virginia Commonwealth University · R01 · FY2014 · HL
Role of Adaptive Immunity in Etiology of Alzheimerâs Disease andAlzheimerâs Disease-Related Dementias
$830,810Douglas C Wallace · Children'S Hosp Of Philadelphia · R01 · FY2023 · AG
Ocular Flare Meter (OFAM) Development Phase II
$830,773Naresh Menon · Chromologic, Llc · R44 · FY2016 · EY
ApoE4, Neurovascular Injury and Cognitive Impairment
$830,704Costantino Iadecola · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · NS
Oral Wound Healing
$830,691Praveen Arany · National Institute Of Dental & Craniofacial Research · ZIA · FY2014 · DE
Vascular smooth muscle cell heterogeneity and disease
$830,638Michael Simons · Yale University · R01 · FY2022 · HL
Next-generation extracellular vesicle biologics to target central nervous system and peripheral reservoirs of HIV
$830,593Kenneth W Witwer · Johns Hopkins University · R01 · FY2019 · AI
Molecular Regulation of Progressive Pulmonary Fibrosis
$830,589Paul Wesley Noble · Cedars-Sinai Medical Center · R35 · FY2024 · HL
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease
$830,544Christie M Ballantyne · Baylor College Of Medicine · R01 · FY2016 · HL
Lipids, Inflammation, and Cardiovascular Risk in Rheumatoid Arthritis
$830,522Katherine Phoenix Liao · Brigham And Women'S Hospital · R01 · FY2018 · HL
Role of Glycosphingolipids in Kidney Disease in Diabetes and Obesity
$830,500Moshe Levi · Georgetown University · R01 · FY2025 · DK
First-in-class TREM-1 inhibitors for neovascular retinal diseases
$830,491Alexander B Sigalov · Signablok, Inc. · R44 · FY2025 · EY
Multi-disciplinary Approach to the Study of Chronic Pelvic Pain (MAPP)
$830,436Karl J Kreder · University Of Iowa · U01 · FY2012 · DK
Fat and Iron-Corrected Quantitative MRI T1 Mapping for Evaluation of Chronic Liver Disease
$830,401Li Feng · New York University School Of Medicine · R01 · FY2025 · DK
Microglia targeted interventions in prodromal Alzheimer's disease stage
$830,339Julia Tcw · Boston University Medical Campus · R01 · FY2023 · AG